New cervical cancer treatment approach could reduce risk of death by 40%, trial results show
A phase three UK trial found that a new approach to administering chemotherapy to cervical cancer patients improved survival risk. Researcher Dr. Mary McCormack and gynecologic oncologist Dr. Brian Slomovitz react to the findings.